Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

As winter brings a rise in coughs, colds, and fevers, it’s often hard to tell if it’s just a seasonal viral, the flu, or ...

A comprehensive eight-year study examining audiological outcomes of newborns screened for congenital cytomegalovirus (cCMV) ...

He pretended to be a Dubai resident who wanted to fly back, for which he wanted to undergo the mandatory RT-PCR test. But he ...

BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global medical technology company, today announced it has received U ...

Nirsevimab continued to provide strong protection against respiratory syncytial virus-associated bronchiolitis in paediatric ...

One of the goals of Co-Diagnostics, Inc., a molecular diagnostic company which developed PCR testing for COVID-19, ...

Q3 2025 Revenue of $21.8 million, an increase of 20% over Q3 2024;Q3 2025 gross profit margin of 81%, a 400-basis point improvement from Q3 ...

Co-Diagnostics (CODX) announced the formation of a newly organized, artificial intelligence business unit, led by Chief Technology & AI Officer ...

Victoria is ramping up its biosecurity defences against H5N1 bird flu, with new federal support to boost emergency preparedness and rapid response ...

Brock did, in fact, find bacteria reproducing inside the hot springs — a discovery critical to the development of polymerase chain reaction, a DNA sequencing method that has advanced biotech, ...